Example: Heart Attack
Clinical Trials on Generalized Morphea
Total 1 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- Hospital, Vannes
- Mayo Clinic
- Assistance Publique - Hôpitaux de Paris
- Pfizer
- AstraZeneca
- First Hospital of Shijiazhuang City
- Novartis Pharmaceuticals
- Assiut University
- GlaxoSmithKline
- Groupe Pasteur Mutualité
- Cairo University
- Amphia Hospital
- Charlotte Gastroenterology and Hepatology
- National Cancer Institute (NCI)
- Mid-Atlantic Nutrition Obesity Research Center
- BKK Mobil Oil
- Universitätsklinikum Tulln
- John Kempen
- M.D. Anderson Cancer Center
- Beijing DMS Pharma Ltd.
- View Full List
Medical Conditions
- Infection Gastrointestinal
- Obesity
- Pre-terminal Cancer
- Stroke
- Hematopoietic and Lymphoid Cell Neoplasm
- Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Breast Cancer
- Corpus Callosum Malformation
- Pain
- Asthma
- Coronary Artery Disease
- Depression
- Prostate Cancer
- Nutritional Status in Hospitalised Geriatric Patients
- ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
- Blood Flow Indexes
- Blood Coagulation Disorder Due to Liver Disease
- Leucocytosis
- Hypertension
- HIV Infections
- View Full List
Drug Interventions
- AC-150A 0.1%
- Iodixanol, Ioversol, Iopromide
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- 100 mg INX-08189 QD
- Dicofenac
- Dexamethasone
- Gemcitabine
- Cyclophosphamide
- Paclitaxel
- Prednisone
- enalapril and other angiotensin converting enzyme inhibitors; losartan and other angiotensin receptor blockers
- M4344 10 mg BIW
- Capecitabine
- Triamcinolone Acetonide 4 mg intravitreal injection
- Cisplatin
- Carboplatin
- CA-008
- Efficacy of Enbrel subcutaneously at Week 36
- docetaxel
- Bevacizumab
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Australia
- Contract Research Organizations in Cambodia
- Contract Research Organizations in France
- Contract Research Organizations in Germany
- Contract Research Organizations in Greece
- Contract Research Organizations in India
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Poland
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Ukraine
- CRO list by country